Algernon Pharmaceuticals Competitors and Similar CompaniesClear all
Algernon Pharmaceuticals's competitors and similar companies include CSL Behring.
 Algernon Pharmaceuticals Algernon Pharmaceuticals is a clinical-stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. | ||
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Vancouver, CA HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees N/A | Employees 7,5692% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) |
For sources of this data, please see the company profile